| |   |   |   |   |   |  |   | Notes | Mar. 31, 2019 |   | Mar. 31, 2018 |  |   | EGP Thousands |   | EGP Thousands |  |   |   |   |   |   |  | Net profit for the period |   | 2,642,347 |   | 2,017,638 |  | Reserve for financial assets at fair value through OCI |   | 2,335,582 |   | (603,484) |  | Total other comprehensive income for the period |   | 4,977,929 |   | 1,414,154 |  |   |   |   |   |   |  |   |   |   |   |   |  | Separate cash flow for the period ended March 31, 2019 |  |   | Notes | Mar. 31, 2019 |   | Mar. 31, 2018 |  |   |   | EGP Thousands |   | EGP Thousands |  |   |   |   |   |   |  | Cash flow from operating activities |   |   |   |   |  | Profit before income tax |   | 3,757,767 |   | 2,869,367 |  | Adjustments to reconcile net profit to net cash provided by operating activities |   |   |   |   |  | Fixed assets depreciation | 24  | 131,898 |   | 94,089 |  | Impairment charge for credit losses | 12  | 634,951 |   | 320,232 |  | Other provisions charges | 29  | 2,077 |   | 26,048 |  | Provisions charges - due from banks | 12  | (7,102) |   | - |  | Provisions charges - financial investments | 12  | (107,122) |   | - |  | Impairment charge for other assets | 23  | 24,814 |   | - |  | Exchange revaluation differences for financial assets at fair value through OCI | 21  | 334,394 |   | 39,053 |  | Intangible assets amortization | 40  | 32,552 |   | 32,552 |  | Impairment charge financial assets at fair value through OCI | 21  | 45,664 |   | (16) |  | Exchange differences in financial investments in subidiary  | 22  | 1,485 |   | 209 |  | Utilization of other provisions  | 29  | 2,461 |   | 245 |  | Other provisions no longer used  | 29  | (164,335) |   | - |  | Exchange differences of other provisions  | 29  | (37,871) |   | 2,578 |  | (Profits) losses from selling financial investments | 21  | (52,041) |   | (146,635) |  | Shares based payments |   | 124,000 |   | 107,302 |  | Operating profits before changes in operating assets and liabilities  |   | 4,723,592 |   | 3,345,024 |  |   |   |   |   |   |  |   |   |   |   |   |  | Net decrease (increase) in assets and liabilities |   |   |   |   |  | Due from banks | 16  | (17,549,341) |   | (29,978,825) |  | Treasury bills and other governmental notes | 41  | 15,781,350 |   | 8,624,987 |  | Financial assets at fair value through P&L | 21  | 2,180,287 |   | 124,989 |  | Derivative financial instruments | 20  | (47,159) |   | (5,392) |  | Loans and advances to banks and customers | 18 - 19 | (6,035,057) |   | (7,195,719) |  | Other assets | 42  | (587,120) |   | (1,232,913) |  | Due to banks | 25  | (3,921,303) |   | 9,474,440 |  | Due to customers | 26  | 8,051,449 |   | 5,354,264 |  | Income tax obligations paid |   | (3,762,070) |   | (2,778,973) |  | Other liabilities | 28  | 3,487,750 |   | 2,608,087 |  | Net cash provided from operating activities |   | 2,322,378 |   | (11,660,031) |  |   |   |   |   |   |  | Cash flow from investing activities |   |   |   |   |  | Payment for purchases of subsidiary and associates |   | - |   | (10,575) |  | Payment for purchases of property, plant, equipment and branches constructions |   | (483,048) |   | (214,488) |  | Proceeds from redemption of financial assets at amortized cost | 21 | 33,452,378 |   | 2,808,013 |  | Payment for purchases of financial assets at amortized cost | 21 | (32,834,360) |   | - |  | Payment for purchases of financial assets at fair value through OCI | 21 | (4,493,603) |   | (10,484,844) |  | Proceeds from selling financial assets at fair value through OCI |   | 4,617,766 |   | 303,449 |  | Net cash used in investing activities |   | 259,133 |   | (7,598,445) |  |   |   |   |   |   |  | Separate cash flow for the period ended March 31, 2019 (Cont.) |   |   |   |   |  |   |   | Mar. 31, 2019 |   | Mar. 31, 2018 |  |   |   | EGP Thousands |   | EGP Thousands |  | Cash flow from financing activities |   |   |  | Increase in long term loans | 27 | (114,541) | 13,092 |  | Dividend paid |   | (2,700,544) | (2,143,177) |  | Net cash used in (provided from) financing activities |   | (2,815,085) | (2,130,085) |  |   |   |   |  |   |   |   |  | Net increase (decrease) in cash and cash equivalent during the period |   | (233,574) | (21,388,561) |  | Beginning balance of cash and cash equivalent |   | 34,303,645 | 49,208,837 |  | Cash and cash equivalent at the end of the period |   | 34,070,071 | 27,820,276 |  |   |   |   |  |   |   |   |   |  | Cash and cash equivalent comprise: |   |   |  | Cash and balances with central bank | 15 | 24,741,584 | 26,182,232 |  | Due from banks | 16 | 51,538,237 | 42,306,844 |  | Treasury bills and other governmental notes | 17 | 33,831,714 | 45,937,458 |  | Obligatory reserve balance with CBE | 15 | (17,837,693) | (20,421,756) |  | Due from banks with maturities more than three months |   | (23,971,797) | (20,155,641) |  | Treasury bills with maturity more than three months |   | (34,231,974) | (46,028,861) |  | Total cash and cash equivalent |   | 34,070,071 | 27,820,276 |  |   |   |   |  |   |   |   | 
  |   |   |   |   |   |   |   |   |   |